Related topics
| Topic | Replies | Views | Activity | |
|---|---|---|---|---|
| Efficacy and Safety of the 3-Month Formulation of Paliperidone Palmitate vs Placebo for Relapse Prevention of Schizophrenia | 0 | 768 | April 1, 2015 | |
| Three-Year Outcomes of 6-Month Paliperidone Palmitate in Adults With Schizophrenia: An Open-Label Extension Study of a Randomized Clinical Trial | 0 | 25 | July 17, 2024 | |
| Long-acting injectable paliperidone palmitate for schizophrenia | 4 | 969 | May 27, 2016 | |
| Most Patients With Schizophrenia Relapse-Free With Paliperidone Palmitate, Open Label Extension Study Finds | 3 | 38 | August 2, 2024 | |
| Janssen Submits New Drug Application to U.S. FDA for Three-Month Paliperidone Palmitate | 3 | 558 | November 19, 2014 |